RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Series A | USD 2,500,000 | ||
|
Sword Health | Series A | USD 8,000,000 | |||
|
|
Sword Health | Seed | USD 4,600,000 | |||
|
Zilico Ltd | Electrical Impedance Spectroscopy (EIS) cancer diagnostic device technology. | Venture | USD 19,000,000 | ||
|
Cardiac Insight Inc | Developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex disease states. | Series C-1 | USD 4,500,000 | ||
|
Sinovision Technology (Beijing) Co Ltd | Developer of computed tomography (CT) scanners. | Venture | CNY 200,000,000 | ||
|
Auris Surgical Robotics Inc | Venture | USD 280,000,000 | |||
|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Seed | PLN 6,500,000 | ||
|
|
StethoMe | Medically certified AI algorithms and device for automatic and remote lung and heart screening. | Seed | USD 2,000,000 | ||
|
Intrinsic Therapeutics Inc | N/A | USD 28,000,000 |
MOST ACTIVE INVESTORS
| IP Group PLC | GB | 4 |
| SV Health Investors LLP | 3 | |
| EDF Ventures | US | 2 |
| Deepbridge Capital LLP | GB | 2 |
| VantagePoint Capital Partners | US | 2 |
| New Enterprise Associates Inc | US | 2 |
| New Leaf Venture Partners | US | 2 |
| Wellington Partners [US] | US | 2 |
| Spray Venture Partners | US | 2 |
| ePlanet Capital | US | 2 |
MOST ACTIVE ACQUIRERS
| Auris Surgical Robotics Inc | US | 1 |
BEST FUNDED
Electrical Impedance Spectroscopy (EIS) cancer diagnostic device technology.
Developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex disease states.
Medically certified AI algorithms and device for automatic and remote lung and heart screening.
Developer of a new patented diagnostic test system that will significantly improve identification and treatment of glaucoma
![[current-page:title] logo](/sites/default/files/styles/thumbnail/public/default_images/_no-logo.png?itok=xgKd-YA_){kind=logo}
Developer of home haemodialysis systems, called “SelfCare”.
eMed Technologies, Inc., privately held, offers a complete technology solution for improving the business of radiology.
High performance nucleic acid purification, enrichment, and sequence detection.